無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

造影剤の世界市場:タイプ(要素化合物、ガドリニウム化合物)、応用領域(神経疾患、癌、心血管疾患)、モダリティ(MRI、X線/CT)別 市場分析と予測 2018年〜2027年

Contrast Media/Contrast Agents Market Size, Share & Trends Analysis Report By Type (Iodinated, Gadolinium-based), By Application (Neurological, Cancer, CVDs), By Modality (MRI, X-ray/CT), And Segment Forecasts, 2018 - 2027

発行 Grand View Research, Inc. 商品コード 639942
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
造影剤の世界市場:タイプ(要素化合物、ガドリニウム化合物)、応用領域(神経疾患、癌、心血管疾患)、モダリティ(MRI、X線/CT)別 市場分析と予測 2018年〜2027年 Contrast Media/Contrast Agents Market Size, Share & Trends Analysis Report By Type (Iodinated, Gadolinium-based), By Application (Neurological, Cancer, CVDs), By Modality (MRI, X-ray/CT), And Segment Forecasts, 2018 - 2027
出版日: 2018年11月14日 ページ情報: 英文 120 Pages
概要

世界の造影剤市場は、2018年から2027年にかけて3.5%のCAGRで推移し、2027年までに69億3,000万米ドル規模の市場に成長することが予測されています。慢性疾患の増加による画像診断および造影剤の利用の増加が当市場の主な成長要因となっています。

当レポートでは、世界の造影剤市場を調査し、市場の概要、タイプ・応用領域・モダリティ・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

  • 市場のスナップショット

第3章 市場変数、動向、範囲

  • 市場区分と範囲
  • 成長見通しマッピング
  • SWOT分析:要素別(政治/法律/経済/技術)
  • ファイブフォース分析

第4章 造影剤市場の分析と予測:タイプ別

  • 市場動向の分析:タイプ別
    • ヨード系造影剤
    • バリウム系造影剤
    • ガドリニウム系造影剤
    • 微小気泡造影剤

第5章 造影剤市場の分析と予測:モダリティ別

  • 市場動向の分析:モダリティ別
    • X線/CT造影剤
    • MRI造影剤
    • 超音波造影剤

第6章 造影剤市場の分析と予測:応用領域別

  • 市場動向の分析:応用領域別
    • 心血管疾患
    • 神経疾患
    • 消化器疾患
    • 腎疾患
    • 筋骨格疾患
    • その他

第7章 造影剤市場の分析と予測:地域別

  • 市場シェアの分析:地域別
  • 北米
  • 欧州
  • アジア
  • その他の地域

第8章 競合情勢

  • 戦略の枠組み
  • 参入企業の分類
  • 企業プロファイル
    • Bayer AG
    • General Electric Company
    • Guerbet
    • Lantheus Medical Imaging, Inc.
    • Bracco Diagnostics, Inc.

第9章 市場の見通し

  • モダリティの概要
  • 競合分析
  • パイプライン分析
図表

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 3 North America contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 4 North America contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 5 U.S. contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 6 U.S. contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 7 U.S. contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 8 Canada contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 9 Canada contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 10 Canada contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 11 Europe contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 12 Europe contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 13 Europe contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 14 U.K. contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 15 U.K. contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 16 U.K. contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 17 France contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 18 France contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 19 France contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 20 Asia contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 21 Asia contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 22 Asia contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 23 Japan contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 24 Japan contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 25 Japan contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 26 India contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 27 India contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 28 India contrast media agents market, by application, 2016 - 2027 revenue (USD Million)
  • TABLE 29 RoW contrast media agents market, by agent type, 2016 - 2027 revenue (USD Million)
  • TABLE 30 RoW contrast media agents market, by modality type, 2016 - 2027 by revenue (USD Million)
  • TABLE 31 RoW contrast media agents market, by application, 2016 - 2027 revenue (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modelling for market share assessment
  • FIG. 5 Market summary, 2017
  • FIG. 6 Market trends & outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Market restrain relevance analysis (Current & future impact)
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 12 Contrast media agents market type outlook: key takeaways
  • FIG. 13 Contrast media agents market: Agent type movement analysis
  • FIG. 14 Global Iodinated contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 15 Barium-based contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 16 Global gadolinium contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 17 Global microbubble contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 18 Contrast media agents market, modality type outlook: key takeaways
  • FIG. 19 Contrast media agents market: Modality type movement analysis
  • FIG. 20 Global x-ray/CT contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 21 Global MRI contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 22 Global ultrasound contrast agents market, 2016 - 2027 (USD Million)
  • FIG. 23 Contrast media agents market application outlook key takeaways
  • FIG. 24 Contrast media agents market: Applications movement analysis
  • FIG. 25 Global cardiovascular disorders market, 2016 - 2027 (USD Million)
  • FIG. 26 Global neurological disorders market, 2016 - 2027 (USD Million)
  • FIG. 27 Global gastrointestinal disorders market, 2016 - 2027 (USD Million)
  • FIG. 28 Global cancer market, 2016 - 2027 (USD Million)
  • FIG. 29 Global nephrological disorders market, 2016 - 2027 (USD Million)
  • FIG. 30 Global musculoskeletal disorders market, 2016 - 2027 (USD Million)
  • FIG. 31 Global other applications market, 2016 - 2027 (USD Million)
  • FIG. 32 Regional market place: Key takeaways
  • FIG. 33 Regional outlook, 2017 & 2027
  • FIG. 34 North America Contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 35 U.S. Contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 36 Canada contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 37 Europe Contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 38 U.K. contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 39 France contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 40 Asia Contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 41 Japan contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 42 India contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 43 RoW contrast media agents market, 2016 - 2027 (USD Million)
  • FIG. 44 Strategy framework
  • FIG. 45 Participant categorization
  • FIG. 46 SWOT Analysis (Bayer)
  • FIG. 47 SWOT Analysis (GE)
  • FIG. 48 SWOT Analysis (Guerbet)
  • FIG. 49 SWOT Analysis (Lantheus)
  • FIG. 50 SWOT Analysis (Bracco)
目次
Product Code: GVR-2-68038-357-7

The global contrast media agents market size is estimated to reach USD 6.93 billion by 2027 and is expected to witness a CAGR of 3.5%, according to a new report by Grand View Research, Inc. Increasing burden of chronic diseases is driving diagnostic imaging procedure volumes as well as utilization of contrast media agents. Also, competitive strategies deployed by key companies are expected to support market growth. Among these, Guerbet, GE, and Bayer were the forerunners with top-selling drugs in their respective portfolios and securing more than 50% of the overall market share in 2017.

Bayer has to its advantage the leading MRI agent, Gadavist/Gadovist, a macrocyclic gadolinium agent. While, Guerbet recently jumped positions in the market since it joined forces with Mallinckrodt. The acquisition has led to a streamlined portfolio of MRI and x-ray/CT contrast media that now hold center position in this market. GE competes with Omnipaque and Visipaque as part of its suite of offerings.Along with increasing chronic disease incidence and prevalence trends, rising demand and use of diagnostic imaging modalities is driven by the advancements in the underlying technology.

These range across equipment and administration technology. Equipment advances include innovation, such as syringeless injectors, which help in achieving greater accuracy in dose delivery, shorter examination time, and higher patient throughput. Regionally, North America is leading the contrast media agents market with significant share. Presence of well-established healthcare infrastructure, availability of advanced technologies, and recent launch of new contrast media agents for specific indications account for the revenue share of this region.

Further key findings from the study suggest:

In 2017, iodinated contrast agents registered maximum sales due to the high penetration of contrast media agents in x-ray and CT procedures driven by availability of non-ionic stable iodinated agents for improved diagnosis

X-ray/CT modality technique was the largest segment in 2017, in terms of sales revenue, due to its wide acceptance and utilization

Cardiovascular Diseases (CVDs) applications segment is expected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/CT contrast agents in U.S. For instance, Lumason was recently approved by the U.S. FDA for use in liver ultrasonography

North America captured the highest revenue in 2017 owing to presence of well-established healthcare infrastructure and availability of advanced technology

Europe and Asia followed in terms of revenue in 2017, attributable to high penetration of contrast agents, usage of diagnostic imaging modalities, and growing presence of domestic companies in Asia

Key companies in the contrast media agents market are Bayer AG, GE Healthcare; Guerbet LLC; Lantheus Medical Imaging, Inc.; Bracco Diagnostics, Inc.; Daiichi Sankyo Co. Ltd.; and Fuji Pharma Co. Ltd.

Table of Contents

Chapter 1: Research Methodology & Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased database
    • 1.1.2 GVR's internal database
  • 1.2 Research Methodology
  • 1.3 Geographic scope & assumptions
  • 1.4 Region-wise market calculation
    • 1.4.1 Region-wise market: Base estimates
    • 1.4.2 Global market: CAGR calculation
  • 1.5 Region-based segment share calculation
  • 1.6 List of Secondary Sources

Chapter 2: Executive Summary

  • 2.1 Market Snapshot

Chapter 3: Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
    • 3.1.1 Market Drivers Analysis
      • 3.1.1.1 Increasing prevalence of long-term diseases and complex comorbidities
      • 3.1.1.2 Technological advancements
      • 3.1.1.3 Competitive Strategies
    • 3.1.2 Market Restraints Analysis
      • 3.1.2.1 Rising concern over accumulation of linear MRI gadolinium agents in the brain
  • 3.2 Penetration & growth prospect mapping
  • 3.3 Contrast media agents - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4: Contrast Media Agents Market: Contrast Agent Type Estimates & Trend Analysis

  • 4.1 Contrast media agents market: Contrast Agent Type Movement Analysis
    • 4.1.1 Iodinated contrast media
      • 4.1.1.1 Iodinated contrast agents market, 2016 - 2027 (USD Million)
    • 4.1.2 Barium-based contrast media
      • 4.1.2.1 Barium-based contrast agents market, 2016 - 2027 (USD Million)
    • 4.1.3 Gadolinium-based contrast media
      • 4.1.3.1 Gadolinium contrast agents market, 2016 - 2027 (USD Million)
    • 4.1.4 Microbubble contrast media
      • 4.1.4.1 Microbubble Contrast Agents market, 2016 - 2027 (USD Million)

Chapter 5: Contrast Media Agents Market: Modality Type & Trend Analysis

  • 5.1 Contrast media agents market: Modality Type Movement Analysis
    • 5.1.1 X-ray/CT Contrast Agents
      • 5.1.1.1 X-ray/CT contrast agents market, 2016 - 2027 (USD Million)
    • 5.1.2 MRI Contrast Agents
      • 5.1.2.1 MRI contrast agents market, 2016 - 2027 (USD Million)
    • 5.1.3 Ultrasound Contrast Agents
      • 5.1.3.1 Ultrasound contrast agents market, 2016 - 2027 (USD Million)

Chapter 6: Contrast Media Agents Market: Application & Trend Analysis

  • 6.1 Contrast media agents market: Applications Movement Analysis
    • 6.1.1 Cardiovascular Disorders
      • 6.1.1.1 Cardiovascular disorders market, 2016 - 2027 (USD Million)
    • 6.1.2 Neurological Disorders
      • 6.1.2.1 Neurological disorders market, 2016 - 2027 (USD Million)
    • 6.1.3 Gastrointestinal Disorders
      • 6.1.3.1 Gastrointestinal disorders market, 2016 - 2027 (USD Million)
    • 6.1.4 Cancer
      • 6.1.4.1 Cancer market, 2016 - 2027 (USD Million)
    • 6.1.5 Nephrological Disorders
      • 6.1.5.1 Nephrological disorders market, 2016 - 2027 (USD Million)
    • 6.1.6 Musculoskeletal Disorders
      • 6.1.6.1 Musculoskeletal disorders market, 2016 - 2027 (USD Million)
    • 6.1.7 Other Applications
      • 6.1.7.1 Others applications market, 2016 - 2027 (USD Million)

Chapter 7: Market Categorization 2: Regional Estimates & Trend Analysis, by Test Type

  • 7.1 Contrast media agents market share by region, 2016 & 2027
  • 7.2 North America
    • 7.2.1 North America Contrast media agents market, 2016 - 2027 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Contrast media agents market, 2016 - 2027 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Contrast media agents market, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Contrast Agent Product Withdrawals
    • 7.3.2 Europe Contrast media agents market, 2016 - 2027 (USD Million)
    • 7.3.3 U.K.
      • 7.3.3.1 U.K. Contrast media agents market, 2016 - 2027 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Contrast media agents market, 2016 - 2027 (USD Million)
  • 7.4 Asia
    • 7.4.1 Asia Contrast media agents market, 2016 - 2027 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan contrast media agents market, 2016 - 2027 (USD Million)
    • 7.4.3 India
      • 7.4.3.1 India contrast media agents market, 2016 - 2027 (USD Million)
  • 7.5 RoW
    • 7.5.1 RoW contrast media agents market, 2016 - 2027 (USD Million)

Chapter 8: Competitive Landscape

  • 8.1 Strategy framework
  • 8.2 Market participation categorization
  • 8.3 Company Profiles
    • 8.3.1 Bayer AG
      • 8.3.1.1 Company overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product overview
      • 8.3.1.4 Strategic initiatives
      • 8.3.1.5 SWOT Analysis
    • 8.3.2 General Electric Company
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Product overview
      • 8.3.2.4 Strategic initiatives
      • 8.3.2.5 SWOT Analysis
    • 8.3.3 Guerbet
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial performance
      • 8.3.3.3 Product overview
      • 8.3.3.4 Strategic initiatives
      • 8.3.3.5 SWOT Analysis
    • 8.3.4 Lantheus Medical Imaging, Inc.
      • 8.3.4.1 Company overview
      • 8.3.4.2 Financial performance
      • 8.3.4.3 Product overview
      • 8.3.4.4 Strategic initiatives
      • 8.3.4.5 SWOT Analysis
    • 8.3.5 Bracco Diagnostics, Inc.
      • 8.3.5.1 Company overview
      • 8.3.5.2 Product overview
      • 8.3.5.3 Strategic Initiatives
      • 8.3.5.4 SWOT Analysis

Chapter 9: Market Outlook

  • 9.1 Modality Outlook
  • 9.2 Competitive Insights
  • 9.3 Pipeline Analysis
Back to Top